Ge, Dongxia
O’Brien, Michael J. http://orcid.org/0000-0001-8036-0978
Savoie, Felix H.
Gimble, Jeffrey M.
Wu, Xiying
Gilbert, Margaret H.
Clark-Patterson, Gabrielle L.
Schuster, Jason D.
Miller, Kristin S.
Wang, Alun
Myers, Leann
You, Zongbing http://orcid.org/0000-0001-5048-2229
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-15-1-0444)
Article History
Received: 6 January 2021
Accepted: 29 October 2021
First Online: 30 November 2021
Competing interests
: M.J.O.B. is a paid consultant of Smith and Nephew, Wright Medical, ExacTech, and Aevumed. J.M.G. is the co-owner and co-founder of for-profit LaCell LLC (that provides the hASCs and stromal medium through a contract), Obatala Sciences Inc., and Talaria Antibodies, as well as a board member of IFATS, Biochimie, JTERM, Stem Cells and Stem Cells & Development, and Netcells, and owns patents related to hASCs and scaffolds. X.W. is the co-owner and co-founder of for-profit LaCell LLC, Obatala Sciences Inc., and Talaria Antibodies, and owns patents related to hASCs and scaffolds. The remaining authors declare no competing interests.